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INTRODUCTION
Hematopoietic and endothelial cells are among the ear-
liest cell types to diff e rentiate in embryonic development.
Their common site of origin in the yolk sac, multiple shared
immunophenotypic markers, and concurrent involvement
by several spontaneous or induced mutations in model
organisms suggest that these 2 cellular lineages derive from
a single pre c u r s o r, the hemangioblast [1]. The subsequent
d i ff e rentiation of hemangioblasts into committed endothe-
lial progenitors, or angioblasts, capable of contributing to
the formation of blood vessels was considered to occur only
in embryogenesis. However, recent studies have demon-
strated the presence of endothelial precursor cells in umbili-
cal cord blood [2] and the peripheral blood of adults [3]. 
Because these circulating endothelial pro g e n i t o r s
a p p a rently could be purified on the basis of their expre s-
sion of membrane antigens also found on hematopoietic
stem cells [2-4], we speculated that they might be trans-
plantable in allogeneic bone marrow transplant (BMT)
recipients. To investigate, we obtained peripheral blood
mononuclear cells from 3 individuals 5 to 52 months after
a sex-mismatched, HLA-compatible BMT. We culture d
the cells on a fibronectin surface with endothelial gro w t h
factors, characterized the phenotype of the cells that
e m e rged, and determined their origin using a polymerase
chain reaction (PCR)-based assay for polymorphic short
tandem repeats (STRs).
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ABSTRACT
Endothelial cell precursors circulate in blood and express antigens found on hematopoietic stem cells, suggesting
that such precursors might be subject to transplantation. To investigate, we obtained adherence-depleted peripheral
blood mononuclear cells from 3 individuals who had received a sex-mismatched allogeneic bone marrow transplant
(BMT) and cultured the cells on fib ronectin-coated plates with endothelial growth factors. The phenotype of the
spindle-shaped cells that emerged in culture was characterized by immunoflu o rescent staining, and the origin of the
cells was determined using a polymerase chain reaction (PCR)-based assay for polymorphic short tandem re p e a t s
(STRs). The cells manifested a number of endothelial characteristics—such as von Willebrand factor, CD31, and
F l k-1/KDR expression; Bandeiraea simplicifolia lectin 1 binding; and acetylated low-density lipoprotein uptake—but
lacked expression of certain markers of activation or diff e rentiation, including intercellular adhesion molecule-1, vas-
cular cell adhesion molecule-1, and the epitope for the anti–endothelial cell antibody P1H12. For each patient and at
all time points studied (ranging from 5 to 52 months after transplantation), STR-PCR analysis showed that culture d
cells and nucleated blood cells came exclusively from the bone marrow donor. These results demonstrate that circ u-
lating endothelial progenitors are both transplantable and capable of long-term repopulation of human allogeneic
BMT re c i p i e n t s .
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MATERIALS AND METHODS
Experimental Subjects 
A p p roval to conduct this study was given by the Institu-
tional Review Board of Vanderbilt University Medical Cen-
ter and the Research and Development Committee of the
Nashville Veterans Affairs Medical Center, both in Nashville,
Tennessee. Three men who had received an HLA-matched
BMT from a sibling donor, in each case a sister, were
e n rolled. Subject 1, a 52-year-old man with chronic myel-
ogenous leukemia, was studied 52 months after transplanta-
tion; subject 2, a 50-year-old man with mantle cell lym-
phoma, was studied 5 months after transplantation; and
subject 3, a 43-year-old man with acute nonlymphocytic
leukemia, was studied 38 months after transplantation. Sub-
ject 1 had mild chronic graft-versus-host disease (GVHD),
and subject 3, although without clinical evidence of GVHD,
was receiving a tapering course of immunosuppressive ther-
apy at the time he was studied. Two-color fluorescence in
situ hybridization (FISH) analysis of peripheral blood or
bone marrow samples showed complete donor chimerism of
hematopoietic cells in all 3 subjects (data not shown).
R e a gents and Antibodies 
1 , 1′- D i o c t a d e c y l - 3 , 3 , 3′, 3′- t e t r a m e t h y l - i n d o c a r b o c y a-
nine–labeled acetylated low density lipoprotein (DiI-acLDL)
was purchased from Molecular Probes (Eugene, OR).
Biotinylated Bandeiraea (G r i ff o n i a) s i m p l i c i f o l i a lectin 1 (BS-1
lectin) was purchased from Vector Laboratories (Burlingame,
CA). Monoclonal antibodies 45C6A and 30Q8A to human
cadherin-5 (vascular endothelial [VE] cadherin) were pro-
vided by ICOS (Bothell, WA) as hybridoma supern a t a n t s .
Rabbit polyclonal antibody to zonula occludens-1 (ZO-1)
was purchased from Zymed (San Francisco, CA). Mouse
monoclonal antibodies JC/70A [5] to CD31 (PECAM-1),
PD7/26 and 2B11 [6] to CD45, and KP1 [7] to CD68, along
with rabbit polyclonal antibody to human von Wi l l e b r a n d
factor (vWF), were purchased from Dako (Carpinteria, CA).
Monoclonal antibodies CH-11 to Flk-1/KDR, P1H12 [8] to
m a t u re endothelial cells, and P2A4 to intercellular adhesion
molecule-1 (ICAM-1, or CD54) were from Chemicon Inter-
national (Temecula, CA). Monoclonal antibody HAE-2 to
vascular cell adhesion molecule-1 (VCAM-1, or CD106) was
obtained from Oncogene Research Products (Cambridge,
MA). Biotinylated secondary antibodies and stre p t a v i d i n –
indocarbocyanine-3 (Cy3) conjugates were purchased fro m
Jackson ImmunoResearch (West Grove, PA ) .
Isolation and In Vitro Culture of Endothelial
P r ogenitors 
F o rty milliliters of anticoagulated peripheral blood was
collected from each patient and diluted 1:3 with phosphate-
b u ff e red saline (PBS) containing 5 mmol/L EDTA and
0.5% bovine serum albumin (BSA) (Life Te c h n o l o g i e s ,
G a i t h e r s b u rg, MD). Mononuclear cells were obtained by
density gradient centrifugation (Ficoll-Hypaque; ICN Bio-
chemicals, Aurora, OH), subjected to 3 cycles of red cell lysis,
washed with PBS containing 5 mmol/L EDTA and
0.5% BSA, and resuspended in 0.3 mL of this solution. The
resulting suspension was diluted to a concentration of 1.3 ×
1 06 cells/mL in Medium 199 (Life Technologies) with
20% fetal bovine serum (Life Technologies), 12 µg/mL
b o v i ne brain extract (Clonetics, San Diego, CA), 50 µ g / m L
gentamicin, and 50 ng/mL amphotericin B. Cells were added
in a volume of 15 mL to 10-cm plastic tissue culture dishes
and incubated overnight at 37°C. The cells that had not
a d h e red to plastic were then transferred with medium to 10-c m
fib ronectin-coated dishes (Becton Dickinson, Bedford, MA).
E v e ry other day, cultures were fed and nonadherent cells
removed by complete changes of medium. Cells used for
immunophenotyping were washed with calcium- and magne-
s i u m - f ree PBS, trypsinized, and replated in fresh medium at a
concentration of 2.0 × 1 05 cells/mL on fibro n e c t i n - c o a t e d
1 6 -well slide chambers (Nunc Lab-Tek; Nalge Nunc Intern a-
tional, Rochester, NY). In cultures terminated for DNA extrac-
tion, cells were trypsinized and processed as described below.
Phenotypic Characterization of Cultured Cells 
The fib ro n e c t i n - a d h e rent cells that remained after 6 days
in culture were trypsinized and transferred to fibro n e c t i n -
coated microwell culture slides for staining. For analysis of
acLDL uptake, DiI-acLDL was diluted in seru m - f re e
Medium 199 to a concentration of 1 µg/mL and added to
wells in aliquots of 200 µL. Cells were incubated for 4 hours
at 37°C and visualized by both phase-contrast and fluores-
cence microscopy.
I m m u n o f l u o rescent staining was carried out on fixed
slides as described [9]. Briefly, microwell cultures were
washed twice with 37°C calcium- and magnesium-free PBS,
incubated in pre w a rmed 4% paraformaldehyde for 5 min-
utes, and washed 3 times with calcium- and magnesium-
f ree PBS. When indicated, cells were permeabilized with
250 mmol/L ammonium sulfate, 10 mmol/L piperazine-
N,N ′-bis(2-ethanesulfonic acid) at pH 6.8, 50 mmol/L
N a C l , 300 mmol/L sucrose, 3 mmol/L MgCl2, and 0.5%
Triton X-100 and washed with calcium- and magnesium-
f ree PBS. After permeabilization, slides were blocked with
2% goat serum in PBS for 30 minutes at room temperature,
treated with an additional blocking reagent (Vector Labora-
tories) to minimize nonspecific binding of biotin/avidin
reagents, and incubated with biotinylated BS-1 lectin
diluted 1:45 in blocking solution. Cells were incubated with
antibodies against cadherin-5, ZO-1, vWF, CD31, Flk-
1/KDR, CD68, CD45, ICAM-1, VCAM-1, and P1H12 for
1 hour at room temperature and washed 3 times with cal-
cium- and magnesium-free PBS. They were then incubated
with a biotin-conjugated secondary antibody for 30 minutes,
then with Cy3-conjugated streptavidin for 30 minutes or,
for lectin binding, Cy3-conjugated streptavidin dire c t l y.
Coverslips were applied with Vectashield mounting medium
(Vector Laboratories), and the cells were examined under a
Zeiss Axioplan microscope equipped for epifluore s c e n c e .
Images were captured using a digital camera with Image-
Pro Plus software (Media Cybernetics, Silver Spring, MD).
Human umbilical vein endothelial cells (HUVECs) (Clonet-
ics) were used as positive controls for expression of ICAM-1 ,
VCAM-1, cadherin-5, and P1H12; peripheral blood mono-
nuclear cells were used as positive controls for expression of
CD45 and CD68.
Allelotyping Analysis of Cultured Cells 
Genomic DNA was isolated from blood (QIAmp Blood
Kit; Qiagen, Valencia, CA) and cultured cells (QIAamp Ti s-
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sue Kit; Qiagen) using a silica gel method according to the
m a n u f a c t u re r ’s instructions. For subject 2, DNA was
obtained from nucleated peripheral blood cells before trans-
plantation, whereas for subject 3, germline DNA was pre-
p a red from a buccal swab (MasterAmp Buccal Swab DNA
Extraction Kit; Epicentre Technologies, Madison, WI). In
the remaining patient (subject 1), gingival bleeding, possibly
related to chronic GVHD, precluded collection of a buccal
sample that was not also contaminated with peripheral
blood. For all 3 BMT recipients, DNA was extracted fro m
nucleated peripheral blood leukocytes at the time blood was
collected for cell culture and also from the cells re m a i n i n g
after 10 days of culture. DNA concentrations were deter-
mined flu o rometrically (DyNA Quant 200; Hoefer Pharm a-
cia Biotech, San Francisco, CA) using a dye-binding method.
F l u o ro c h rome-conjugated primers for the STR loci
TH01, TPOX, CSF1PO, F13A1, FES/FPS, FGA, and
D21S11 and for the X-Y homologous gene amelogenin were
p u rchased from Perkin-Elmer (now PE Biosystems, Foster
C i t y, CA). The loci to which these primers anneal contain
s h o rt (3– to 7–base pair [bp]), tandemly repeated sequences
and are highly polymorphic in the number of such re p e a t s
p resent. Amplification of β-globin sequences was perf o rm e d
b e f o re STR-PCR analysis to ensure that sample DNAs could
be efficiently amplified. PCR was carried out in glass capil-
l a ry tubes in an air-driven thermal cycler (Rapid Cycler;
Idaho Technologies, Idaho Falls, ID) using 25 ng genomic
DNA in a 10-µL reaction volume containing 5.0 µL sample
DNA, 1.0 µL H2O, 1.0 µL of 10× b u ff e r, and 1.0 µL
deoxynucleoside triphosphate mixture (each at a concentra-
tion of 2 mmol/L); 1.0 µL primer mixture (each at a concen-
tration of 10 µmol/L); and 1.5 U Taq polymerase (Life Te c h-
nologies). Denaturation, annealing, and extension times were
optimized for each primer pair, with a total of 30 cycles used
in all reactions. After amplification, 1.5 µL reaction mixture
was combined with 4.5 µL gel loading buffer (75% for-
mamide, 5 mmol/L EDTA, and 0.1% blue dextran, pH 8.0),
heated to 95°C, and chilled on ice. Samples were loaded in a
volume of 1.0 µL/well on 4.25% acrylamide–8 mol/L ure a
gels in an ABI 377 automated DNA sequencer (Perkin-
Elmer) and electro p h o resed for a minimum of 8 hours. Fluo-
rescence DNA fragment analysis was carried out with the
GeneScan Analysis (version 2.1) software package (Perkin-
Elmer). Dedicated pipettes with disposable, barr i e r-style tips
w e re employed with all solutions used for DNA extraction or
PCR, and control samples lacking DNA template were
included in every PCR reaction to monitor for contamina-
tion. Under the conditions employed, the amelogenin
primers were capable of detecting a subpopulation of male
cells present in a frequency of ≤10% in mixtures of cells fro m
male and female subjects (data not shown).
RESULTS
Cell Culture 
Small, spindle-shaped cells possessing the phenotype of
immature endothelial cells (see below) first became evident
3 to 4 days after inoculating fibronectin-coated dishes with
adherence-depleted peripheral blood mononuclear cells. By
5 to 6 days, few to no cells were removed with medium
changes, and after a week in culture, a homogeneous popu-
lation of adherent, spindle-shaped cells re p resenting some
0.1% to 0.3% of total mononuclear cells initially plated
were present. Cells were generally distributed over the sur-
face of the culture dish (Figure 1A), although small clusters
(Figure 1B) or linear arrays (not shown) of cells were occa-
sionally seen. The appearance of these spindle-shaped cells
was identical to that described by others [3,10,11].
Phenotypic Characterization of Blood-Deriv e d
Endothelial Cells 
After their transfer to fibronectin-coated micro w e l l
slides, cells were characterized for uptake of acLDL and
e x p ression of a number of immunophenotypic markers.
M o re than 90% of cultured cells exhibited DiI-acLDL
incorporation, BS-1 lectin binding, and immunoflu o re s c e n t
staining for vWF, ZO-1, and CD31 expression (Figure 2 and
Table 1). Consistent with the apparent absence of connec-
tions between cells,  the junctional protein ZO-1 was
o b s e rved in an intracellular location [12]. Weak staining was
also noted for vascular endothelial growth factor (VEGF)
re c e p t o r-2 (Flk-1/KDR), which increased with the addition
of recombinant VEGF to cultures (not shown). No staining
was noted with antibodies to the monocyte/macro p h a g e
marker CD68, the leukocyte common antigen CD45, or
F i g u r e 1. Morphology of blood-derived endothelial progenitors. Phase con-
trast photomicrograph of individual spindle-shaped cells (A) and a cluster of
these cells (B) obtained 7 days after culturing plastic adherence–depleted
peripheral blood mononuclear cells on fibronectin-coated dishes with endothelial
growth factors. Original magnification ×20.
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ICAM-1, VCAM-1, cadherin-5, or P1H12. All these anti-
bodies reacted with HUVEC or peripheral blood mononu-
clear cell controls processed in parallel. Because of the con-
siderable phenotypic overlap between endothelial and
hematopoietic cells, none of the markers used could be con-
s i d e red endothelial specific. In aggregate, however, these
results indicate that under the specific culture conditions
employed, a homogeneous cell population with endothelial
characteristics proved capable of proliferating, diff e re n t i a t-
ing, or both. 
Genotypic Analysis of Blood-Derived Endothelial Cells 
Each patient in this study had received a sex-mis-
matched transplant, which assured that, at minimum, the
primers for the X- and Y-linked amelogenin locus [13]
would be informative in determining the origin of their
cells. In subject 2, from whom DNA was isolated before
transplantation, and in subject 3, from whom a buccal sam-
ple free of blood contamination was obtained, 7 primer pairs
for STRs, in addition to the amelogenin primers, were
tested for their ability to discriminate between donor and
recipient. Two or more STR loci were identified in which
one or both alleles were unique to donor or recipient (Fig-
ure 3 and Table 2). Only the primer set for the amelogenin
locus was used in the 1 patient (subject 1) from whom nei-
ther pretransplantation nor germline DNA was available.
STR-PCR analysis of peripheral blood leukocyte DNA
c o n firmed FISH results showing complete donor chimerism
of hematopoietic cells (Table 2). Because both lymphoid and
myeloid cells were present in the peripheral blood of these
subjects at the time they were studied (ie, 5 to 52 months after
transplantation), it is probable that complete lympho-hemato-
poietic reconstitution had occurred in all 3. PCR analysis of
DNA from cultured cells similarly revealed that each patient’s
c i rculating endothelial progenitors were derived exclusively
f rom his bone marrow donor (Figure 3 and Table 2).
Validation that these methods could have detected mixed
chimerism, had it been present, was obtained by analysis of
Figure 2. Selected results of phenotyping analysis of blood-derived endothelial
progenitors. Fluorescence photomicrograph of 1,1 ′- d i o c t a d e c y l - 3 , 3 , 3′, 3′-
tetramethyl-indocarbocyanine–labeled acetylated low density lipoprotein uptake
(A) and von Willebrand factor expression (B) by spindle-shaped cells cultured
as described in text. A considerably greater number of cells were present in the
well shown in B compared with the well shown in A.
Table 1. Summary of Results of Phenotypic Analysis of Cultured Cells*
Antigen Antibody or Ligand Staining, Binding, or Uptake
von Willebrand factor Rabbit polyclonal antibody Strongly positive
CD31 (PECAM-1) Monoclonal antibody JC/70A Strongly positive
Scavenger receptor DiI-AcLDL Strongly positive
Endothelial a-D-galactosyl epitope Bandeiraea simplicifolia lectin Strongly positive
ZO-1 Rabbit polyclonal antibody Positive
Flk-1/KDR Monoclonal antibody CH-11 Weakly positive
Activated/circulating endothelial cells Monoclonal antibody P1H12 Negative
CD106 (VCAM-1) Monoclonal antibody HAE-2 Negative
CD54 (ICAM-1) Monoclonal antibody P2A4 Negative
Cadherin-5 (VE cadherin) Monoclonal antibodies 45C6A and 30Q8A Negative
CD45 (leukocyte common antigen) Monoclonal antibodies PD7/26 and 2B11 Negative
CD68 (human macrophage) Monoclonal antibody KP1 Negative
*Results of the immunophenotypic analysis carried out on cultured cells. Immunofluorescence staining with the antibodies indicated, Bandeiraea sim -
plicifolia lectin binding, and 1,1′-dioctadecyl-3,3,3′,3′-tetramethyl-indocarbocyanine–labeled acetylated low density lipoprotein (DiI-acLDL) uptake
are described in the text. Human umbilical vein endothelial cells (HUVECs) and Ficoll-Hypaque–purified peripheral blood mononuclear cells were
processed in parallel as controls; HUVECs were used as controls for P1H12, CD106, CD54, and cadherin-5 staining; Ficoll-Hypaque–purifie d
peripheral blood mononuclear cells were used as controls for CD45 and CD68 staining.
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d e fined mixtures of peripheral blood leukocyte DNA fro m
bone marrow donors and recipients before transplantation
and of nucleated blood cell DNA pre p a red from individual
recipients at various times before hematopoietic re c o n s t i t u-
tion (data not shown). Indeed, as re p o rted for other flu o re s-
cence-based assays of chimerism [14,15], a linear corre l a t i o n
was observed between the amount of a given DNA species in
sample mixtures and that determined by PCR to be pre s e n t
(data not shown). These results indicate that the circ u l a t i n g
hematopoietic cells and endothelial progenitors in these allo-
geneic BMT recipients were donor derived within 5 months
and remained so for at least 4 years after transplantation.
DISCUSSION
These studies confirm that endothelial precursor cells
a re present in the peripheral blood of humans [3,16] and
establish that such cells are transplantable in allogeneic
BMT recipients. Their existence had been suspected fro m
the observation that synthetic vascular grafts often become
seeded with endothelial cells on their luminal surf a c e s
[17,18] and from the finding that direct application of bone
marrow cells to such grafts was particularly effective in pro-
moting their endothelialization [19]. While this study was in
progress, published results of experiments in canine [20] and
murine [4,21,22] BMT recipients indicated that endothelial
precursors that homed to intravascular grafts (canine recipi-
ents) and circulated in blood (murine recipients) similarly
derived from the marrow donor, although those experiments
w e re carried out at short intervals from transplantation.
Because aspiration of peripheral blood is nearly unavoidable
in human bone marrow harvests, the possibility that a circu-
lation- rather than bone marrow–derived progenitor was
transplanted cannot be excluded. At minimum, however,
these results establish that the source of endothelial precur-
sor cells in circulation is transplantable and emphasize the
potential of such cells for long-term engraftment.
Because our subjects had undergone complete lympho-
hematopoietic reconstitution with donor-derived cells by the
time of analysis, it was particularly important to distinguish
Figure 3. Selected results of allelotyping analysis of blood-derived endothelial progenitors. A. Electrophoretogram of short tandem repeat–polymerase chain reac-
tion (STR-PCR) results from subject 1 using primers for the X-Y homologous gene amelogenin. Panel 1 depicts allelotype of this recipient obtained with peripheral
blood leukocyte DNA extracted before transplantation, with the unique 106–base pair (bp), Y chromosome–derived allele shown shaded. Fifty-two months after
transplantation, only the 112-bp, X chromosome–derived allele characteristic of the female marrow donor (panel 2) was detected on PCR analysis of DNA pre-
pared from nucleated peripheral blood cells of the marrow recipient (panel 3) and of DNA prepared from the spindle-shaped cells cultured from that subject’s blood
(panel 4). B. Composite electrophoretogram of STR-PCR results from subject 2 using primers for the amelogenin locus and for an STR in the factor XIII A sub-
unit gene (F13A1). Alleles unique to the patient’s cells before transplantation are shown shaded (panel 1). These alleles were undetectable 5 months after trans-
plantation, with only the 112-bp, X chromosome–derived amelogenin allele and the 2 donor-specific F13A1 alleles detected on PCR analysis of DNA prepared
from cultured spindle-shaped cells (panel 2) and nucleated peripheral blood cells (data not shown). The scale to the left of each electrophoretogram indicates fluores-
cence intensity. The scale at the top corresponds to the distance fragment migrated in the gel.
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the cells that we cultured from hematopoietic cells. Using
the identical conditions employed by Asahara et al. [3], but
with much more highly purified CD34+ cell populations (data
not shown), we were unsuccessful at culturing any endothelial
cells. It may be significant, however, that Asahara et al. found
readdition of CD34– cells to result in a much higher yield of
spindle-shaped endothelial cells than could be obtained with
C D 3 4+ cells alone [3]. Despite starting with a mononuclear
cell preparation depleted only of cells that would adhere to
plastic, the cells that ultimately populated our cultures were
morphologically and immunophenotypically homogeneous.
This finding suggests that the growth factors, fibro n e c t i n
substratum, and possible paracrine effects of other cells ini-
tially present in culture restricted the growth and diff e re n t i a-
tion of all but endothelial cells. However, even if a small num-
ber of hematopoietic cells had persisted until the time the
c u l t u res were terminated, the only circumstance under which
such contamination could have accounted for the observ e d
complete donor chimerism of the cultured cells would have
been for all such cells to have been hematopoietic.
The endothelial nature of the cultured cells was con-
firmed by their (1) expression of CD31 and vWF, (2) bind-
ing of a lectin (BS-1) widely recognized by endothelial cells,
and (3) avid uptake of acLDL. Although the scavenger
receptor [23] and vWF [24] are also expressed by macro-
phages and megakaryocytes, re s p e c t i v e l y, and CD31 is
expressed by certain hematopoietic cells [25-27], the lack of
CD68 and CD45 expression in the cells that emerged in
c u l t u re distinguished them from lymphocytes and macro-
phages present in circulation. Furthermore, their expression
of CD31 and vWF differentiated them from mesenchymal
stem cells [28], which are present in bone marrow and capa-
ble of giving rise to multiple cell types, possibly including
endothelial cells [29]. In addition, mesenchymal stem cells
a re not mobilized into peripheral blood by colony-stimu-
lating factors [30], in contrast to mouse [4] and human
endothelial progenitors [31] (our unpublished data) and, at
least in patients with lysosomal and peroxisomal storage
diseases, appear not to be transplantable with allogeneic
bone marrow [32]. F i n a l l y, although endothelial cells have
themselves been observed to circulate in blood, part i c u-
larly under conditions of vascular injury [8,33-36], they are
n o rmally present in very small numbers [8,37] and expre s s
antigens (in particular the epitope recognized by the
P1H12 monoclonal antibody [8]) that were not identified
in the population of cells we cultured. Still, although the
spindle-shaped cells we and others have cultured fro m
plastic adherence–depleted mononuclear cell pre p a r a t i o n s
[10,11] and mixtures of CD34+ and CD34– cells [3] are
clearly endothelial in type, they are not identical, morpho-
logically or immunophenotypically, to mature endothelial
cells. Whether they re p resent the adult counterparts of an
e m b ryonic Flk-1+ P E C A M+ VE cadherin– endothelial pre-
cursor [38], are at an intermediate stage of diff e re n t i a t i o n
because of specific culture conditions [10], or, as suggested
by xenograft studies [3], are themselves angioblasts will
require further study.
Three recent studies provide additional support for the
existence of circulating endothelial progenitor cells in
humans [10,31,39]. Although each study used different cul-
t u re conditions, cells possessing the appearance and
immunophenotype of endothelial cells emerged 18 days
[10], 2 weeks [31], and 9 days [39] after initiation of cultures
with CD34+ [10], AC133+ F l k - 1 / K D R+ [31], and P1H12+
[ 3 9 ] peripheral blood cells. Lin et al. [39], in fact, studied
4 recipients of sex-mismatched BMTs 5 to 20 months post-
transplantation. In contrast to our results, however,
endothelial cells of both donor and recipient genotype were
noted in their cultures, although donor cells showed the
greatest expansion in cell number at late times [39]. Previ-
ous studies by Solovey et al. [8] documented the presence of
mature, P1H12-reactive endothelial cells in circulation, and
although they avoided any possibility of monocyte contami-
nation, their use of P1H12-conjugated immunomagnetic
beads to isolate endothelial progenitors may account for the
mixed chimerism of their endothelial cell cultures. 
Our finding that circulating endothelial progenitors in
human BMT recipients were completely donor derived
m o re than 4 years after transplantation indicates that the
cell from which they arose must be either long-lived or
c a pable of self-renewal. Murray [40] posited a common p re-
cursor for hematopoietic and endothelial cells in embryonic
development, and a cell with this developmental capacity
was recently purified from gastru l a t i o n - s t a ge mesoderm i n
chick embryos [41] and murine embryonic stem cell–derived
e m b ryoid bodies [42]. Whether the hemangioblast is also
p resent in adults, however, awaits studies in which it is
genetically marked and that marker identified in both
endothelial and hematopoietic descendants. Independent of
whether there are common or independent stem cells for
these lineages, the endothelial precursors present in the
blood of these human allogeneic BMT recipients appear to
have long-term repopulating ability. Remarkably, adult bone
m a rrow also contains progenitors for a number of mes-
enchymal [28,43] and even epithelial [44] cell types.
The capacity of circulating human endothelial cell pre-
cursors to contribute to blood vessel repair or assembly is
unknown, although their murine and canine counterpart s
have been shown to traffic to sites of physiologic and patho-
logic neovascularization [3,4,21,22] and to be deposited on
intravascular grafts [20]. Although the finding that circulat-
ing endothelial precursors are capable of long-term repopu-
Table 2. Summary of Results of Allelotyping Analysis of Cultured Cells
Subject 1 Subject 2 Subject 3
Interval from bone marrow transplantation to analysis, mo 52 5 38
Informative markers Amelogenin Amelogenin, TPOX, F13A1, FGA Amelogenin, THO1
Origin of nucleated blood cells Donor Donor Donor
Origin of cultured cells Donor Donor Donor
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lation suggests that they could be used for adoptive cell
t r a n s f e r, with [45] or without genetic modification, more
work is needed to determine these precursors’ relationship
to hematopoietic stem cells, their site of production, and the
vascular beds to which they are able to contribute.
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